Federal, State and Local Officials Scheduled to Attend Ceremony
CHESTER, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) announced that it will commemorate the 10th anniversary of its incorporation with a celebration for employees on Wednesday, Sept. 12, at Municipal Field (Gazebo Park) in Chester, New Jersey. Federal, state and local officials are scheduled to attend and participate in a ceremony recognizing Adams for its decade of success as a specialty pharmaceutical company focused on the treatment of respiratory disorders.
Adams, best known for its Mucinex(R) and Delsym(R) cough and cold products and the nationwide Mr. Mucus(TM) consumer advertising campaign, commenced operations in Fort Worth, Texas in September 1997. In April 2004, the Company relocated its corporate headquarters from Fort Worth to Chester, New Jersey. Adams currently employees nearly 500 people and its Chester facility houses more than 80 of its employees. The Company has expanded its headquarter operations twice since relocating to Chester in 2004 and doubled its portfolio of marketed respiratory products this year.
"On the occasion of this important milestone, I applaud our employees, whose talents and tireless efforts have fueled Adams' phenomenal growth in the past several years," said Michael J. Valentino, president & CEO. "I'm proud of our accomplishments and I look forward to a second decade of success with multiple new product introductions and our planned expansion into the prescription respiratory market."
"I congratulate Adams Respiratory Therapeutics on its 10-year anniversary, and the tremendous growth and success that this company has achieved in such a short period of time," said Stanley Kosierowski, COO and SVP business support, New Jersey Economic Development Authority, who is scheduled to attend the celebration on September 12. "It is New Jersey's good fortune to have companies like Adams come to our state, where they create jobs, become good neighbors and corporate citizens, and continue New Jersey's fine tradition of improving public health by providing important medicines for the entire nation."
In August 2007, Adams was named to Deloitte & Touche's prestigious Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area. Adams was ranked No. 7 overall, based on achieving a revenue growth rate of 1,638 percent from 2002 to 2006.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
For additional information about Adams, please visit the web site at http://www.adamsrt.com.
|SOURCE Adams Respiratory Therapeutics, Inc.|
Copyright©2007 PR Newswire.
All rights reserved